Dark‐field hyperspectral imaging for label free detection of nano‐bio‐materials
- 5 August 2020
- journal article
- review article
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 13 (1) , e1661
Abstract
Nanomaterials are playing an increasingly important role in cancer diagnosis and treatment. Nanoparticle (NP)‐based technologies have been utilized for targeted drug delivery during chemotherapies, photodynamic therapy, and immunotherapy. Another active area of research is the toxicity studies of these nanomaterials to understand the cellular uptake and transport of these materials in cells, tissues, and environment. Traditional techniques such as transmission electron microscopy, and mass spectrometry to analyze NP‐based cellular transport or toxicity effect are expensive, require extensive sample preparation, and are low‐throughput. Dark‐field hyperspectral imaging (DF‐HSI), an integration of spectroscopy and microscopy/imaging, provides the ability to investigate cellular transport of these NPs and to quantify the distribution of them within bio‐materials. DF‐HSI also offers versatility in non‐invasively monitoring microorganisms, single cell, and proteins. DF‐HSI is a low‐cost, label‐free technique that is minimally invasive and is a viable choice for obtaining high‐throughput quantitative molecular analyses. Multimodal imaging modalities such as Fourier transform infrared and Raman spectroscopy are also being integrated with HSI systems to enable chemical imaging of the samples. HSI technology is being applied in surgeries to obtain molecular information about the tissues in real‐time. This article provides brief overview of fundamental principles of DF‐HSI and its application for nanomaterials, protein‐detection, single‐cell analysis, microbiology, surgical procedures along with technical challenges and future integrative approach with other imaging and measurement modalities.This article is categorized under: Diagnostic Tools > in vitro Nanoparticle‐Based Sensing Diagnostic Tools > in vivo Nanodiagnostics and Imaging Implantable Materials and Surgical Technologies > Nanoscale Tools and Techniques in SurgeryKeywords
Funding Information
- Louisiana Board of Regents (LEQSF (2017‐20)‐RD‐A‐04)
This publication has 161 references indexed in Scilit:
- Label-free in vitro toxicity and uptake assessment of citrate stabilised gold nanoparticles in three cell linesParticle and Fibre Toxicology, 2013
- Quantitative Imaging of Protein Secretions from Single Cells in Real TimeBiophysical Journal, 2013
- Raman and SERS microscopy for molecular imaging of live cellsNature Protocols, 2013
- Wide-field spectral imaging of human ovary autofluorescence and oncologic diagnosis via previously collected probe dataJournal of Biomedical Optics, 2012
- Evaluation of hyperspectral technology for assessing the presence and severity of peripheral artery diseaseJournal of Vascular Surgery, 2011
- An Optofluidic Nanoplasmonic Biosensor for Direct Detection of Live Viruses from Biological MediaNano Letters, 2010
- Identification of different bacterial species in biofilms using confocal Raman microscopyJournal of Biomedical Optics, 2010
- In vivo hyperspectral confocal fluorescence imaging to determine pigment localization and distribution in cyanobacterial cellsProceedings of the National Academy of Sciences, 2008
- Label-Free Plasmonic Detection of Biomolecular Binding by a Single Gold NanorodAnalytical Chemistry, 2008
- Use of plasmon coupling to reveal the dynamics of DNA bending and cleavage by single EcoRV restriction enzymesProceedings of the National Academy of Sciences, 2007